Related Experiment Video
Updated: May 5, 2026
12:14
CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
3.9K
A standardized staining protocol for L1CAM on formalin-fixed, paraffin-embedded tissues using automated platforms
Mina Fogel1, Ayelet Harari, Elisabeth Müller-Holzner
1Kaplan Medical Center, Rehovot - Israel.
The International Journal of Biological Markers
|November 19, 2013
Summary
Optimized immunohistochemical staining protocols for L1 cell adhesion molecule (L1CAM) improve cancer biomarker detection. These standardized methods enhance L1CAM analysis in various malignancies for reliable laboratory use.
Area of Science:
- Oncology
- Biomarker Discovery
- Immunohistochemistry
Background:
- L1 cell adhesion molecule (L1CAM) is frequently overexpressed in human cancers.
- L1CAM overexpression is a prognostic biomarker in several malignancies, including type I endometrial carcinomas.
Purpose of the Study:
- To develop and optimize immunohistochemical staining protocols for L1CAM detection.
- To establish reliable and standardized methods for L1CAM analysis in various cancer types.
Main Methods:
- Optimization of immunohistochemical staining procedures for L1CAM.
- Utilized a commercially available primary antibody and detection reagents.
- Validated protocols on both automated (VENTANA™) and semi-automated (BioGenix i6000) platforms.
Main Results:
- Achieved optimized and reliable immunohistochemical staining for L1CAM.
- Demonstrated successful staining on both automated and semi-automated platforms.
- Protocols provide a basis for standardized L1CAM detection across laboratories.
Conclusions:
- Developed standardized immunohistochemical protocols for L1CAM detection.
- Optimized methods ensure reliable L1CAM biomarker analysis in diverse malignancies.
- These protocols facilitate consistent L1CAM assessment in clinical and research settings.
